Clinical Trial: A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy Volunteers

U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07798505) titled 'A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy Volunteers' on Aug. 27.

Brief Summary: The purposes of this clinical study are

1. To see how the new drug (HMB-003) under study is tolerated in healthy volunteers, and if there are any important side effects.

2. To measure the amount of HMB-003 in the body after injection.

Study Start Date: Aug. 17

Study Type: INTERVENTIONAL

Condition: Healthy Adult Participants

Intervention: DRUG: HMB-003

HMB-003 will be administered subcutaneously as a single dose

DRUG: Placebo

Placebo will be administered subcutaneously as a single...